Clinical Trial Update: Zr89 + PET Companion Trial [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating Zirconium-89 as a PET imaging companion for melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Zirconium-89 (zirconium-89)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Melanoma (Skin) | EARLY_Phase 1 | Status: COMPLETED